1 study found for:    19223496 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Study of Fulvestrant +/- Everolimus in Post-Menopausal, Hormone-Receptor + Metastatic Breast Ca Resistant to AI
Condition: Metastatic Breast Cancer
Interventions: Drug: Fulvestrant;   Drug: Everolimus;   Drug: Placebo (for Everolimus)

Indicates status has not been verified in more than two years